GENE ONLINE|News &
Opinion
Blog

Diabetes Mellitus
Novo Nordisk Acquire Catalent for $16.5 Billion, Enhancing Obesity Drugs Production Capacity
2024-02-07
Taiwan’s AMS BioteQ Develops a New Antimicrobial Dressing Which Accelerates Diabetes Wound Healing
2021-09-22Partner
Vertex Inks $1.2B Pact with Feng Zhang Cofounded Startup to Develop Gene Therapies for Blood Diseases
2021-08-25
Eli Lilly Infuses $1 Billion into Protomer Acquisition to Procure “Next-Gen” Insulin Products
2021-07-15
FDA Rejection of Type 1 Diabetes Drug Impacts Provention Bio’s Stocks
2021-07-07
Long Standing Rivalry in Diabetes Market Intensifies as Eli Lilly’s Drug Outshines Novo’s in Head to Head Trial
2021-03-05
Study Shows New Diabetes Drug Induces Remarkable Weight Loss in Obese Patients
2021-02-15
Novo Nordisk’s Acquisition of Emisphere Could Embolden Diabetics to Cut Back on Needles
2020-11-08
Medtronic Bags FDA Authorization for Pioneering Medical Device to Combat Pediatric Diabetes
2020-09-02
R&D
Spotlight: The Many Facets of AstraZeneca’s Farxiga
2020-05-15
R&D
Diabetes: Novel Amylin, Insulin Coformulation Could Aid Blood-Sugar Control
2020-05-14
Peptide Therapeutics Market: Promise for a Painless Future
2020-03-18
Novo Nordisk Pharma Ltd. Partners with Health2Sync in Japan, Bringing Digital Diabetes Management to Healthcare Providers and Patients
2019-03-05
A longevity chronicle: The development of anti-aging pill
2018-08-14
LATEST
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-06-13
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
Advancing Healthcare Accessibility and Sustainable Development
2024-06-11
New CRISPR Method Enables Gene Edits in Cockroaches and All Insects
2024-06-11
EVENT
Scroll to Top